PATRICIA ODHAM: Open Payments
NPI 1750457024 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,848 in 68 payments from 18 companies in 2025. Trend: 2023 $1,208 · 2024 $2,301 · 2025 $1,848
Food & beverage: $1,848
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $626 |
| Otsuka America Pharmaceutical, Inc. | 7 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $158 |
| Neurocrine BioSciences, Inc. | 2 | $127 |
| Axsome Therapeutics, Inc. | 5 | $104 |
| ABBVIE INC. | 5 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $90 |
| Lundbeck LLC | 4 | $77 |
| Alkermes, Inc. | 4 | $76 |
| Indivior Inc. | 3 | $65 |
Products named: HETLIOZ, FANAPT, REXULTI, CAPLYTA, INGREZZA, Auvelity, VRAYLAR, SUBLOCADE.
Industry payments across NC — which companies pay providers there.
